Rohto Pharmaceutical Co.,Ltd. (FRA:UC1)

Rohto Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,152	3,122	4,148	4,375	3,125	2,595
Market Cap Growth	-21.63%	-24.73%	-5.20%	40.03%	20.41%	-9.13%
Enterprise Value	3,076	3,049	3,742	3,986	2,821	2,288
PE Ratio	15.32	16.30	21.88	23.96	20.05	20.12
PS Ratio	1.64	1.64	2.50	2.65	2.11	1.86
PB Ratio	1.87	1.86	2.74	2.94	2.29	2.15
P/TBV Ratio	2.64	2.48	2.86	3.16	2.49	2.27
P/FCF Ratio	17.27	18.16	25.77	28.15	24.82	29.84
P/OCF Ratio	13.36	13.69	19.77	20.43	15.47	16.84
EV/Sales Ratio	1.69	1.60	2.26	2.41	1.91	1.64
EV/EBITDA Ratio	9.89	9.56	12.50	13.93	10.61	10.38
EV/EBIT Ratio	14.00	12.83	15.20	17.17	13.50	13.58
EV/FCF Ratio	16.85	17.73	23.25	25.64	22.41	26.31
Debt / Equity Ratio	0.16	0.19	0.04	0.05	0.12	0.05
Debt / EBITDA Ratio	0.83	0.97	0.21	0.28	0.60	0.28
Debt / FCF Ratio	1.49	1.80	0.40	0.52	1.26	0.72
Asset Turnover	0.79	0.80	0.83	0.82	0.80	0.82
Inventory Turnover	2.34	2.47	2.59	2.72	2.71	2.55
Quick Ratio	1.47	1.55	1.82	1.75	1.74	1.79
Current Ratio	2.17	2.30	2.47	2.37	2.30	2.36
Return on Equity (ROE)	12.90%	11.94%	13.59%	13.25%	12.42%	11.31%
Return on Assets (ROA)	5.90%	6.26%	7.66%	7.17%	7.04%	6.20%
Return on Invested Capital (ROIC)	11.73%	13.63%	19.28%	18.52%	17.47%	14.91%
Return on Capital Employed (ROCE)	11.90%	11.80%	15.50%	14.60%	13.90%	12.90%
Earnings Yield	6.53%	6.13%	4.57%	4.17%	4.99%	4.97%
FCF Yield	5.79%	5.51%	3.88%	3.55%	4.03%	3.35%
Payout Ratio	22.86%	22.81%	17.70%	17.73%	16.28%	17.71%
Buyback Yield / Dilution	-0.53%	-0.04%	0.00%	0.00%	-	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.